Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/4/23 → 12/31/25 |
Funding
- Werewolf Therapeutics Incorporated: $26,269.00
A Multicenter Phase I/Ib Dose Escalation Study of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Patients with Selected Advanced or Metastatic Solid Tumors
- Pili, Roberto (PI)
Project: Research